NDAORALTABLET, EXTENDED RELEASE
Approved
Nov 2016
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Data completeness
5/8 — Partial
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BONJESTA is an oral extended-release tablet containing doxylamine succinate and pyridoxine hydrochloride (vitamin B6) approved for treating nausea and vomiting of pregnancy. The mechanism of action is unknown, though doxylamine is a sedating antihistamine and pyridoxine is a B-vitamin cofactor. The combination represents a non-teratogenic approach to pregnancy-related nausea management.
$0.039BPart D
Peak6.8 years to LOEBONJESTA is at peak lifecycle with modest Part D spending, indicating a stable but modest commercial footprint with limited team expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Started May 2022
274 enrolled
Morning Sickness
Career Relevance
BONJESTA shows minimal job linkage (1 role) concentrated in administrative/business support, not commercial or medical functions, reflecting its niche pregnancy indication and small commercial footprint. Career growth is limited; most opportunities are likely maintenance-level marketing and sales support for a specialty, regulated indication.
Office Clerk
Worked on BONJESTA at Duchesnay? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.